Proposed amendment AB 713, if passed, would hopefully provide clarity to businesses working with clinical research data. The amendment proposes matching CCPA de-identification standards to those set forth in the Health Insurance Portability and Accountability Act (HIPAA), in addition to equally important clarifications for life sciences companies, health care providers and medical researchers. In particular, AB 713 covers five major principles:
- HIPAA De-identification
- Privacy Disclosure
- Business Associates
- Medical Research
- Product and Medical Device Tracking
This proposed amendment will hopefully be a source of guidance for those seeking to comply with CCPA, and businesses in this space should watch the amendment process.
This article is presented for informational purposes only and is not intended to constitute legal advice.